Leukemia

- 9-Ethyl-6-mercaptopurine (NSC-14575): preliminary clinical observations.

- A clinical trial of sarcolysin in acute leukemia.

- A comparison of the effectiveness of standard dose 6-mercaptopurine, combination 6-mercaptopurine and DON, and high-loading 6-mercaptopurine therapies in the treatment of acute leukemia in children: results of cooperative study.

- A comparison of the effectiveness of standard dose 6-mercaptopurine, combination 6-mercaptopurine and DON, and high-loading 6-mercaptopurine therapies in treatment of the acute leukemias of childhood: results of a coperative study.

- A family with an XXXXY male, a leukaemic male, and two 21-trisomic mongoloid females.

- Acute leukaemia and Klinefelter's syndrome.

- An introductory statement on the treatment of leukemia.

- Antibody therapy of acute and chronic leukemias. The development of antibody-based therapies for the treatment of both acute and chronic leukemias have undoubtedly been one of the most important advances in...

- Autosomal inactivation.

- BEYOND THE CARIES.

- Changing concepts concerning leukemia.

- Chemotherapy of acute leukemia in Japan.

- Chromosome studies in human leukaemia.

- Clinical trials with AB-100 in children with acute leukemia. Preliminary report.

- Clinical trials with cyclophosphamide in the treatment of acute leukemia in children.

- Comparative evaluation of ACTH and hydrocortisone used alone and in sequence with 6-mercaptopurine in the treatment of acute leukemia in children -- preliminary report of a cooperative study.

- Continuing long-term remission after cyclophosphamide(NSC-26271) therapy for canine leukemia.

- Creutzfeldt-Jakob disease and growth hormone therapy.

- Current and future aspects on the clinical use of Ara-C in leukemia. Proceedings from a symposium held at the 3rd European Conference on Clinical Oncology and Cancer Nursing, June 19, 1985, in Stockholm.

- Cyclophosphamide (Cytoxan) in acute leukemia.